Bio-Rad Laboratories, Inc.BIONYSE
Loading
Free Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank56
3Y CAGR-54.8%
5Y CAGR-21.5%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-54.8%/yr
Quarterly compound
5Y CAGR
-21.5%/yr
Recent deceleration
Percentile
P56
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 33.52% |
| Q3 2025 | 25.99% |
| Q2 2025 | -25.86% |
| Q1 2025 | 17.54% |
| Q4 2024 | -18.73% |
| Q3 2024 | 80.57% |
| Q2 2024 | 86.94% |
| Q1 2024 | -23.67% |
| Q4 2023 | -27.66% |
| Q3 2023 | -15.43% |
| Q2 2023 | 1.66% |
| Q1 2023 | 43.48% |
| Q4 2022 | 362.79% |
| Q3 2022 | -146.05% |
| Q2 2022 | 106.33% |
| Q1 2022 | -84.81% |
| Q4 2021 | -41.41% |
| Q3 2021 | 49.15% |
| Q2 2021 | 39.52% |
| Q1 2021 | -61.70% |
| Q4 2020 | 112.30% |
| Q3 2020 | 56.32% |
| Q2 2020 | 79.99% |
| Q1 2020 | -70.25% |
| Q4 2019 | 101.29% |
| Q3 2019 | -48.45% |
| Q2 2019 | 589.59% |
| Q1 2019 | -62.23% |
| Q4 2018 | 27.13% |
| Q3 2018 | -21.36% |
| Q2 2018 | 288.59% |
| Q1 2018 | -69.59% |
| Q4 2017 | 421.96% |
| Q3 2017 | -74.84% |
| Q2 2017 | 134.50% |
| Q1 2017 | -291.54% |
| Q4 2016 | 310.54% |
| Q3 2016 | -73.35% |
| Q2 2016 | 239.20% |
| Q1 2016 | -510.94% |